Skip to main content
NCBI home page
Springer logoLink to Springer
. 2014 Oct 12;49(1):97–105. doi: 10.1007/s12020-014-0435-3

Leptin at gender-specific concentrations does not affect glucose transport, expression of glucose transporters and leptin receptors in human lymphocytes

Monika Pliszka 1, Bożenna Oleszczak 1,✉, Leszek Szablewski 1
PMCID: PMC4412833  PMID: 25306890

Abstract

Leptin shows pleiotropic effects in organisms including an important role in the regulation of glucose homeostasis. Elevated serum leptin, particularly in obese individuals, is a warning sign of energy imbalance, hyperinsulinemia, insulin resistance and other metabolic risk factors that are strongly associated with type 2 diabetes. Obesity is also related to a higher rate of infections and immune function deterioration may in part ensue from decreased glucose uptake as the main energy source for lymphocytes. The aim of this study was to investigate the effect of physiologic and low pathophysiologic gender-specific leptin concentration found in lean and obese subjects on glucose transport, the expression of glucose transporters and leptin receptors in human peripheral blood lymphocytes. Isolated lymphocytes were incubated with human leptin at gender-specific concentrations observed in normal weight and obese subjects. Glucose uptake in lymphocytes was determined using nonmetabolizable radiolabeled deoxy-d-glucose. The expression of GLUT1, 3, 4 and leptin receptors was investigated using methods of immunocytochemistry and flow cytometry. Leptin at concentrations used in the study does not change glucose transport into lymphocytes and seems to have no influence on the expression of glucose transporters and leptin receptors. Further studies are necessary to address the relationship between leptin, glucose transport and the lymphocytes’ function in obesity.

Keywords: Leptin, Leptin receptor, Deoxy-d-glucose, Lymphocytes, Glucose transporters

Introduction

Leptin is a hormone that plays a key role in metabolic processes and immune functions. Plasma circulating leptin levels directly correlate to total body fat mass and increase proportionally in obesity [9]. Serum leptin level depends on gender and leptin is found to be from 2.35 to 3.5-fold higher in females [18, 19] than in males matched for body mass [43]. Elevated leptin levels coexist not only with obesity but also with diabetes and metabolic syndrome [7], the states that are connected with impaired immunity [2, 13].

Leptin has been recognized as an important factor for modulating the immune responses. Leptin receptors (ObR) are expressed in several cell types of innate and adaptive immunity including lymphocytes [34]. Studies on animals and humans with complete leptin deficiency showed markedly reduced numbers of lymphocytes with impaired humoral responses [5]. There is also an evidence that leptin has effects on innate and acquired immune responses [11, 23]. Leptin stimulates the secretion of other proinflammatory cytokines in the innate immune system such as IL-1, IL-6 and TNF-α [25], and increases phagocytic activity of macrophages [29]. In relation to the acquired immune system, leptin treatment enhances proliferation and suppresses apoptosis of T lymphocytes [26, 40]. Recent studies have indicated that leptin also activates human peripheral blood B cells to induce secretion of IL-6, IL-10, and TNF-α [1].

Though obesity and its associated complications like type 2 diabetes or metabolic syndrome are well defined, little is known about the impact of obesity on immune functions per se. Obesity is associated with decreased immunocompetence [24] and immunity deterioration is related to the grade of obesity [32]. Obese subjects are highly susceptible to infectious diseases, some types of cancer [32, 37] and have lower lymphoproliferative responses to mitogens [8]. Obesity also leads to increased levels of leptin creating a proinflammatory state which may affect lymphocytes number, function [10] and the activation of immune cells [12]. Several obesity-associated changes such as leptin resistance, hyperinsulinemia, excessive inflammation, and altered glucose metabolism which are required for the functionality of lymphocytes could affect the immune response [2]. Moriguchi et al. [35] proposed that the decreased lymphoproliferative response observed in obese rats may be, in part, due to decreased glucose uptake as the main energy source for lymphocytes and may be associated with the decreased expression of Glut1. Unfortunately there is a lack of research in the area concerning human lymphocytes. Moreover it remains unclear whether data from rodent studies also apply to humans [30].

Lymphocytes are cells that have high metabolism with extreme dependency on glucose as a source of energy [36]. Some studies indicate that lymphocytes require glucose metabolism for normal survival and function [28]. Lymphocytes have been found to express GLUT1, GLUT3 and GLUT6 that are primarily responsible for glucose transport in the resting state [14, 31]. In lymphocytes of diabetic patients and women with polycystic ovary syndrome as well as in lymphocytes incubated in high glucose in medium GLUT4 is also expressed [38, 39, 49]. Many studies have found that T cells increase glucose uptake during an immune response [33]. Regulation of T cell glucose uptake and Glut1 is critical, as low glucose prevent appropriate T cell responses [20] and can suppress immunity [54].

It seems that the mechanism affecting impaired immunity in obesity is not fully understood. For that reason more research is necessary to understand what factors are contributing to reduced immunocompetence in obesity state. We chose leptin from among several factors in obesity to determine its role in glucose transport and expression of glucose transporters in lymphocytes. In our study we used the cells derived from lean subjects to exclude the influence of other obesity-associated factors that may affect lymphocytes functions.

It is clear that leptin acts as a hormone that links metabolic processes and immune functions. Based on findings that leptin exerts its effects on lymphocytes and in some types of cells it can stimulate transport of glucose it seems interesting that leptin may be a factor that impact glucose transport into human lymphocytes.

The aim of this study was to investigate the effect of physiologic and low pathophysiologic gender-specific leptin concentration found in lean and obese subjects on glucose transport, the expression of glucose transporters and leptin receptors in human peripheral blood lymphocytes.

Materials and methods

Subjects

It has been shown that age and obesity are accompanied by leptin resistance [41], so the study was undertaken in 100 young, normal weight subjects (50/50 W/M). Written informed consent was obtained from all participants after approval by the Bioethical Committee of the Medical University of Warsaw. Subjects were excluded if they had a history of any serious illness (including diabetes in the family) and other that may affect insulin sensitivity or if they used medications during 3 months preceding the study. The basic characteristics of the examined subjects are presented in Table 1. Anthropometric measurements were done on the day of blood samples collection. Blood glucose was assayed in capillary using a glucometer (Contour, Bayer). The study was carried out according to the principles of the Helsinki Declaration (updated in Edinburgh).

Table 1.

Characteristics of subjects participated in the study

Women Men
n 50 50
Age (years) 23.4 ± 2.3 24.2 ± 1.6
Height (cm) 168.4 ± 4.6 184.2 ± 3.6
Weight (kg) 62.9 ± 3.5 78.2 ± 4.7
BMI (kg/m2) 22.3 ± 1.3 23.1 ± 1.4
Waist (cm) 80.1 ± 4.2 98.4 ± 2.5
Glucose (mg/dl) 91.7 ± 1.1 93.3 ± 1.9
Open in a new tab

Isolation of lymphocytes from the blood

Blood samples were collected in the morning, after an overnight fast, into tubes with heparin. Lymphocytes were isolated within next 2 h by means of centrifugation in Histopaque 1077 (Sigma-Aldrich) gradient, according to the manufacturers’ instructions. The isolated cells were rinsed three times by centrifugation (1,800 rpm, 10 min, 24  C) in PBS. After this procedure cell density in 1 ml of PBS was counted using the Bürker chamber.

Incubation of lymphocytes with human leptin

Lymphocytes were incubated for 24 h with or without (control sample) human recombinant leptin (R&D Systems) at physiologic (4 ng/ml for men and 8 ng/ml for women) and low pathophysiologic (8 ng/ml for men and 32 ng/ml for women) concentrations. The concentrations of leptin used in the present study were based on studies in which serum leptin level were measured in lean (BMI 20–25) and obese (BMI 30–35) men and women respectively [17, 27, 42].

Lymphocytes were incubated in sterile Petri dishes (2.5 × 106 cells in each dish) in DMEM no glucose medium (Gibco) supplemented with 10 % fetal bovine serum, 100 μg/mL of streptomycin and 80 mg/dL of glucose (equivalent of normoglycemia) in a humidified 37 °C, 5 % CO2 incubator. After incubation, cells were rinsed from the medium and suspended in 1 mL of transport solution (20 mM Hepes, 150 mM NaCl, 5 mM KCl, 5 mM MgSO4, 1.2 mM KH2PO4, 25 mM CaCl2, 2 mM pyruvic acid, pH 7.4) [21].

Lymphocytes viability control test

The test was conducted to verify the survival of the cells during the experiment. To 290 µL of cellular suspension, 1.5 µL of deoxy-d-glucose 2-[3H(G)] (8.0 Ci/mmol; Perkin Elmer) was added. After 60 min, 1 % solution of trypan blue was added at 1:1 volume ratio. The number of dead lymphocytes in a sample of 500 cells was counted using a light microscope.

Intracellular transport of deoxy-d-glucose into lymphocytes

Glucose uptake in lymphocytes was determined using nonmetabolizable radiolabeled hexose–2-deoxy-d-glucose, considered the gold standard for examining glucose transport [51]. The study was carried out according to the method described by Kaliman et al. [21] with a partial modification [48].

To 290 µL of cellular suspension (about 3 × 105 lymphocytes) 1.5 µL of deoxy-d-glucose 2-[3H(G)] (8.0 Ci/mmol; Perkin Elmer) and 7.5 µL of PBS were added. The non-specific uptake of tritium-labeled deoxy-d-glucose was assessed using 7.5 µL of cold “stop solution” (50 mmol/L of d-glucose in PBS, 4 °C) instead of PBS solution.

In order to investigate the dynamics of deoxy-d-glucose uptake by lymphocytes, the incubation time with isotope equaled 15, 30, and 60 min. After this time, 200 µL of cold “stop solution” was added to each probe. Lymphocytes (about 3 × 105 cells) were lysed by adding 50 µL of lysing solution (1.1 mmol/L NaOH; 0.1 % SDS). 24 h later 25 µL of lysed cells (about 1.5 × 105 lymphocytes) was taken to evaluate the deoxy-d-glucose uptake.

The amount of deoxy-d-glucose uptake was measured with a liquid scintillation counter (Microbeta Trilux Wallac). Radioactivity was evaluated in cpm (curie per minute). The label uptake was assessed basing on results of total label accumulated at given time minus the nonspecific uptake of deoxy-d-glucose.

Immunocytochemistry

Lymphocytes (about 5 × 104 from each group) were dried and endogenic peroxidase was blocked by adding 200 μL of 3 % H2O2 solution. Then lymphocytes were placed in blocking buffer (1 % bovine serum albumin in PBS) with 2 % goat serum (Sigma). After 30 min mouse monoclonal antibody (1:200) against extracellular domain of human leptin receptor (R&D Systems) was added and then horseradish peroxidase-conjugated goat anti-mouse IgG (1:1000) (Chemicon International Inc. Ca). The negative control sample (for exclusion of non-specific binding of antibodies) consisted of lymphocytes incubated without the first antibody. The same procedure was used in the case of glucose transporters. The antibodies used were rabbit polyclonal antibody aimed against intracellular C-terminus of human GLUT1, GLUT3 and GLUT4 (1:100) and horseradish peroxidase-conjugated goat anti-rabbit IgG (1:2000) (Chemicon International Inc. Ca).

The antigen–antibody complex was visualized using DAB according to the manufacturers’ instructions (Sigma-Aldrich). The presence of investigated proteins was assessed using a light microscope (800×).

Flow cytometry

Lymphocytes (about 3 × 105) from each probe were washed in buffer for FACS (PBS without Mg2+ and Ca2+ with the addition of 2 % fetal bovine serum and 0.002 % sodium azide) by centrifugation (1,300 rpm, 10 min, 4 °C). Cells were permeabilized using 100 μL of Perm2 (Becton–Dickinson) for 10 min. After washing, cells were suspended in 100 μL of buffer for FACS and placed on ice. Samples were incubated for 60 min with 2 μL of polyclonal rabbit antibodies appropriate with: anti-GLUT1, anti-GLUT3 and anti-GLUT4 (Chemicon International Inc. Ca) synthetic peptides corresponding to the C-terminus of human GLUT at a 1:50 dilution. The secondary antibody was 3 μL of swine anti-rabbit IgG-FITC (Dako Cytomation). Cells were incubated on ice for 30 min in the dark. The control sample (negative) was incubated only with the secondary antibody. The supernatant was removed, and 0.5 mL of washing buffer for FACS with 1 % formaldehyde were added.

For investigating the expression of leptin receptors in plasma membrane, the same procedure was used as in the case of GLUT proteins, excluding permeabilization. As the first antibody, 2 μL (500 μg/mL) of mouse monoclonal antibody against extracellular domain of human leptin receptor (R&D Systems) was used. Phycoeritrin-conjugated goat anti-mouse IgG (1:200) (R&D Systems) was used as the secondary antibody.

The samples were analyzed using the FACS Calibur flow cytometer (Becton-Dickinson) fitted with an argon laser (wavelength, 488 nm) and CellQuest software.

Statistical analysis

The results were presented as mean ± SD for males and females separately. Statistical analysis was performed by two-way ANOVA with replication for continuous variables. A P value <0.05 was considered statistically significant.

Results

Lymphocyte viability control test

The test demonstrated that the applied research method did not have a significant impact on lymphocyte survival. A similar percentage of dead lymphocytes (about 5 %) were observed in individual samples.

Deoxy-d-glucose uptake by lymphocytes

In analyzed time points (15, 30 and 60 min.) cpm value increased which meant that after passage of time the amount of deoxy-d-glucose transported into cells was bigger. So deoxy-d-glucose uptake studied in females and males lymphocytes has a clearly growing tendency. However, leptin treatment has not caused statistically significant differences in glucose transport in comparison to control lymphocytes. Figure 1 presents the deoxy-d-glucose uptake by females and males lymphocytes properly in dependence on leptin concentrations in the incubating medium.

Fig. 1.

Fig. 1

Open in a new tab

The intensity of deoxy-d-glucose uptake by females lymphocytes (a) and males lymphocytes (b) in dependence on leptin concentrations in incubating medium. The results (n = 20 for each gender) were presented as mean ± SD. Statistical analysis was performed by two-way ANOVA with replication. Differences between control and leptin-treated lymphocytes were not statistically significant. Normal leptin refers to physiologic level: 4 ng/ml for men and 8 ng/ml for women. Elevated leptin refers to low pathophysiologic level: 8 ng/ml for men and 32 ng/ml for women

Immunocytochemistry

In all investigated females and males samples, irrespective of leptin concentrations, single positive colored cells have been observed suggesting the presence of leptin receptors (ObR) in lymphocytes. Negative control did not return color reaction in any of the samples. It is to note that many lymphocytes did not show positive reaction with antibody against ObR. When investigating GLUT proteins, positive cells have been found in all of the samples, independently of leptin concentrations. However, no differences in color intensity between lymphocytes incubated in different leptin concentrations have been found in males and females, respectively.

All lymphocytes that were colored, showed similar intensity of immunological reaction. That is why in Fig. 2 we show only an exemplary result of immunocytochemical detection of GLUT4 and leptin receptor.

Fig. 2.

Fig. 2

Open in a new tab

Immunocytochemical detection of GLUT4 and leptin receptors in lymphocytes. a Negative control for females lymphocytes incubated without the first antibody. The arrow shows an exemplary negative cell. b Females lymphocytes incubated in elevated leptin concentration showed positive reaction against GLUT4. The arrow shows an exemplary lymphocyte with positive reaction against GLUT4. c Negative control for males lymphocytes incubated without the first antibody. The arrow shows an exemplary negative cell. d Males lymphocytes incubated in elevated leptin concentration showed positive reaction against leptin receptor. The arrow shows an lymphocyte with positive reaction against leptin receptor. The arrow with a star shows an lymphocyte without positive reaction against leptin receptor

Flow cytometry

In order to obtain quantitative values that described expression of investigated proteins, the flow cytometry analysis was used. In females only a few percent of lymphocytes showed the presence of leptin receptors (Fig. 3), irrespectively of leptin concentration and differences between particular samples were not statistically significant. Incubation with different leptin concentration had also no impact on the percent of cells expressed GLUT transporters (Fig. 3). Mean intensity of fluorescence (MIF) makes possible the quantitative comparison of investigated proteins in cells. When particular GLUT and lepin receptors are reported as MIF, no differences have been found irrespective of leptin concentrations (Fig. 4). Similarly, in male lymphocytes different leptin concentrations had no effect on the percent of cells which expressed leptin receptors and particular GLUT transporters (Fig. 3) as well as on MIF values (Fig. 4). Figure 5 shows representative histograms of GLUT1 from flow cytometry analysis of females samples incubated in different leptin concentration.

Fig. 3.

Fig. 3

Open in a new tab

Percent of females and males lymphocytes showing expression of GLUT proteins and leptin receptors. The results (n = 20 for each gender) were presented as mean ± SD. Statistical analysis was performed by two-way ANOVA with replication. Differences between control and leptin-treated lymphocytes were not statistically significant Normal leptin refers to physiologic level: 4 ng/ml for men and 8 ng/ml for women. Elevated leptin refers to low pathophysiologic level: 8 ng/ml for men and 32 ng/ml for women

Fig. 4.

Fig. 4

Open in a new tab

Mean intensity of fluorescence of particular GLUT proteins and leptin receptor (LR) in females and males lymphocytes. The results (n = 20 for each gender) were presented as mean ± SD. Statistical analysis was performed by two-way ANOVA with replication. Differences between control and leptin-treated lymphocytes were not statistically significant. Normal leptin refers to physiologic level: 4 ng/ml for men and 8 ng/ml for women. Elevated leptin refers to low pathophysiologic level: 8 ng/ml for men and 32 ng/ml for women

Fig. 5.

Fig. 5

Open in a new tab

Representative histograms of GLUT1 from flow cytometry analysis of females samples incubated in different leptin concentration. The first antibody used was polyclonal rabbit antibody against GLUT1. The secondary antibody was swine anti-rabbit IgG-FITC. a control without leptin; b normal leptin concentration; c elevated leptin concentration; d control sample (negative) without antibody against GLUT1

The obtained result suggests that leptin in our experiment does not affect the quantity of GLUT proteins in the whole cells and leptin receptors in the cell membrane.

Discussion

The current study has been the first to investigate the effect of low pathophysiologic leptin concentration found in obese subjects on glucose transport, the expression of glucose transporters and leptin receptors in human lymphocytes. The results showed that independent of leptin concentration used, there was no effect on glucose uptake as well as on glucose transporters and leptin receptors in lymphocytes of lean subjects.

According to Sahu [44] in hypothalamus leptin and insulin share a similar PI3K (phosphatidylinositol-3-kinase) intracellular signaling pathway that is thought to play a role in glucose uptake and metabolism [16]. In lymphocytes the PI3K pathway has been show to promote Glut1 cell surface trafficking and activity [50]. In the absence of these signals Glut1 remains intracellular and may restrict glucose uptake [20].

The results of our study have demonstrated that elevated leptin concentration typical for obese subjects did not change deoxy-d-glucose transport into lymphocytes. It appears that this fact is in opposition to the findings of Moriguchi et al. [35] who suggested that obesity coexisted with increased leptin concentration in rats may decrease glucose uptake by lymphocytes. On the other hand many researchers have shown the effect of leptin on glucose uptake in different peripheral tissues. In rat and mouse skeletal muscle cells leptin is able to inhibit or stimulate glucose uptake in vitro [3, 4, 6, 22, 47]. Sweeney et al. [47] showed the effect of leptin on glucose uptake in rat muscle cells but leptin level in their experiments was very high (100 nM = 1,600 ng/mL), several times higher than in obese human subjects (with BMI from 30 to 35) and in comparison to those used in our study.

In the present study the lack of differences in glucose transport between control and leptin-treated lymphocytes may result from the lack of change in the percent of lymphocytes expressing investigated GLUT transporters. Mean intensity of fluorescence which is a sign of amount of GLUT protein in the cell also shows no difference in all samples.

The obesity state is connected with impaired glucose metabolism as well as the role of GLUTs. Different leptin concentrations used in our study, typical for normal weight and obese subjects, had no effect on the expression of GLUTs in lymphocytes. However, according to Saucillo et al. [46] leptin acts directly on activated T cells to allow glucose uptake and metabolic reprogramming. Lymphocytes in our experiments were not stimulated with any additional factors apart from leptin and probably behaved as resting cells. It seems that leptin alone in concentration used in our study is not a sufficient factor for the activation of lymphocytes. The studies of Saucillo et al. [46] indicated that the ability of leptin to upregulate T cell Glut1 expression and glucose metabolism was observed only in activated lymphocytes and resting T cells did not increase glucose metabolism following leptin therapy.

The effective leptin action on immune system cells requires the expression of specific receptors on the surface of cells [45]; Zhao et al. [53]. Górska and Wąsik [15] observed the expression of leptin receptors on B and T cells derived from bone marrow and peripheral blood in children. This study has revealed a dozen of ObR positive B and T cells in peripheral blood. A small number of cells expressing leptin receptors was indicated by Zarkesh-Esfahani et al. [52]. They found leptin receptors only in peripheral lymphocytes B, but in lymphocytes T leptin receptors were not present. The percentage of ObR positive lymphocytes in our study was similar to the results of Zarkesh-Esfahani et al. [52]. This fact may also suggest that ObR positive cells in our study belong to B cells.

Leptin receptors in the cell membrane show similar mean intensity of fluorescence in lymphocytes incubated without leptin in comparison to those incubated in different leptin concentrations. This suggests that the amount of protein in the cell membrane was the same in all ObR positive lymphocytes. It is a possibility that resting lymphocytes have a constant amount of leptin receptors on their cell surface and leptin at concentrations used in our experiments exerts no effect. In the present paper we failed to find the effect of different leptin concentrations on the expression of leptin receptors in lymphocytes. Probably this results from the fact that investigated lymphocytes were not activated.

In conclusion, we have demonstrated that leptin as a single factor had no effect on the intensity of glucose transport into human lymphocytes across genders. The lack of leptin action on glucose transport may be caused by the lack of differences in the expression of glucose transporters in cells incubated in low and elevated leptin concentration. Leptin concentrations used in the present study have also no impact on the percentage of ObR positive lymphocytes and the amount of leptin receptors on the surface of cells. Further studies including obese patients and/or high pathophysiologic and pharmacologic leptin concentration will be necessary to address the relationship between leptin, glucose transport, and lymphocyte function in obesity.

Acknowledgments

This work was supported by the Polish Ministry of Science and Higher Education (Grant No. N N401 009035)

Conflict of interest

The authors declare that there is no conflict of interest.

References

  • 1.Agrawal S, Gollapudi S, Su H, Gupta S. Leptin activates human B cells to secrete TNF-α, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway. J. Clin. Immunol. 2011;31(3):472–478. doi: 10.1007/s10875-010-9507-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bandaru P, Rajkumar H, Nappanveettil G. The impact of obesity on immune response to infection and vaccine: an insight into plausible mechanisms. Endocrinol. Metab. Syndr. 2013;2:2. [Google Scholar]
  • 3.Bates SH, Gardiner JV, Jones RB, Bloom SR, Bailey CJ. Acute stimulation of glucose uptake by leptin in l6 muscle cells. Horm. Metab. Res. 2002;34:111–115. doi: 10.1055/s-2002-23192. [DOI] [PubMed] [Google Scholar]
  • 4.Berti L, Kellerer M, Capp E, Haring HU. Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: evidence for a PI3-kinase mediated effect. Diabetologia. 1997;40:606–609. doi: 10.1007/s001250050722. [DOI] [PubMed] [Google Scholar]
  • 5.Busso N, So A, Chobaz-Péclat V, Morard C, Martinez-Soria E, Talabot-Ayer D, Gabay C. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J. Immunol. 2002;168(2):875–882. doi: 10.4049/jimmunol.168.2.875. [DOI] [PubMed] [Google Scholar]
  • 6.Ceddia RB, William WN, Jr, Curi R. Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: evidence for an effect of leptin on glucose uptake and decarboxylation. Int. J. Obes. Relat. Metab. Disord. 1999;23:75–82. doi: 10.1038/sj.ijo.0800762. [DOI] [PubMed] [Google Scholar]
  • 7.Cha JJ, Hyun Y, Jee YW, Lee MJ, Han KH, Kang S, Han SY, Cha DR. Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen- activated protein kinase/extracellular signal-regulated kinase pathway. Kidney Res. Clin. Pract. 2012;31:177–185. doi: 10.1016/j.krcp.2012.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chandra RK, Kutty KM. Immunocompetence in obesity. Acta Paediatr. Scand. 1980;69(1):25–30. doi: 10.1111/j.1651-2227.1980.tb07024.x. [DOI] [PubMed] [Google Scholar]
  • 9.Considine RV, Sinha M, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, et al. Serum immunoreactive-leptin concentration in normal-weight and obese humans. N. Engl. J. Med. 1996;334(5):292–295. doi: 10.1056/NEJM199602013340503. [DOI] [PubMed] [Google Scholar]
  • 10.Crum-Cianflone NF, Roediger M, Lynn E, Ganesan A, Weintrob A, Johnson E, Agan BK, The Infectious Disease Clinical Research Program HIV Working Group Impact of weight on immune cell counts among HIV-infected persons. Clin. Vaccine Immunol. 2011;18(6):940–946. doi: 10.1128/CVI.00020-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Dardeno TA, Chou SH, Moon HS, Chamberland JP, Fiorenza CG, Mantzoros CS. Leptin in human physiology and therapeutics. Front. Neuroendocrinol. 2010;31(3):377–393. doi: 10.1016/j.yfrne.2010.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.de Heredia FP, Gómez-Martínez S, Marcos A. Obesity, inflammation and the immune system. Proc. Nutr. Soc. 2012;71(2):332–338. doi: 10.1017/S0029665112000092. [DOI] [PubMed] [Google Scholar]
  • 13.DeFuria J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, Nersesova YR, Markham D, Strissel KJ, Watkins AA, Zhu M, Allen J, Bouchard J, Toraldo G, Jasuja R, Obin MS, McDonnell ME, Apovian C, Denis GV, Nikolajczyk BS. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. PNAS. 2013;110(13):5133–5138. doi: 10.1073/pnas.1215840110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Fu Y, Maianu L, Melbert BR, Garvey WT. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol. Dis. 2004;32:182–190. doi: 10.1016/j.bcmd.2003.09.002. [DOI] [PubMed] [Google Scholar]
  • 15.Górska E, Wąsik M. Differences in the expression of leptin receptors on bone marrow and peripheral blood cells. Cent. Eur. J. Immunol. 2012;37(4):332–337. doi: 10.5114/ceji.2012.32721. [DOI] [Google Scholar]
  • 16.Harlan SM, Rahmouni K. PI3K signaling: a key pathway in the control of sympathetic traffic and arterial pressure by leptin. Mol. Metab. 2013;2(2):69–73. doi: 10.1016/j.molmet.2013.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hickey MS, Israel RG, Gardiner SN, Considine RV, McCammon MR, Tyndall GL, Houmard JA, Marks RH, Caro JF. Gender differences in serum leptin levels in humans. Biochem. Mol. Med. 1996;59:1–6. doi: 10.1006/bmme.1996.0056. [DOI] [PubMed] [Google Scholar]
  • 18.Hu FB, Chen C, Wang B, Stampfer MJ, Xu X. Leptin concentrations in relation to overall adiposity, fat distribution, and blood pressure in a rural Chinese population. Int. J. Obes. Relat. Metab. Disord. 2001;25(1):121–125. doi: 10.1038/sj.ijo.0801480. [DOI] [PubMed] [Google Scholar]
  • 19.Ingelsson E, Larson MG, Yin X, Wang TJ, Meigs JB, Lipinska I, Benjamin EJ, Keaney JF, Jr, Vasan RS. Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample. J. Clin. Endocrinol. Metab. 2008;93(8):3149–3157. doi: 10.1210/jc.2008-0207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Jacobs SR, Herman CE, MacIver NJ, Wofford JA, Wieman HL, Hammen JJ, Rathmell JC. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J. Immunol. 2008;180(7):4476–4486. doi: 10.4049/jimmunol.180.7.4476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kaliman P, Vinals F, Testar X, Palacin M, Zorzano A. Disruption of GLUT1 glucose carrier trafficking in L6E9 and Sol8 myoblasts by the phosphatidylinositol 3-kinase inhibitor wortmannin. Biochem. J. 1995;3(12):471–477. doi: 10.1042/bj3120471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kamohara S, Brucelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature. 1997;389:374–377. doi: 10.1038/38717. [DOI] [PubMed] [Google Scholar]
  • 23.Lam QL, Lu L. Role of leptin in immunity. Cell. Mol. Immunol. 2007;4:1–13. [PubMed] [Google Scholar]
  • 24.Lamas OA, Marti A, Martinez JA. Obesity and immunocompetence. Eur. J. Clin. Nutr. 2002;56(suppl3):S42–S45. doi: 10.1038/sj.ejcn.1601484. [DOI] [PubMed] [Google Scholar]
  • 25.Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, et al. Leptin regulates proinflamatory immune responses. FASEB J. 1998;12(1):57–65. [PubMed] [Google Scholar]
  • 26.Londraville RL, Macotel Y, Duff RJ, Easterling MR, Liu Q, Crespi EJ. Comparative endocrinology of leptin: assessing function in a phylogenetic context. Gen. Comp. Endocrinol. 2014 doi: 10.1016/j.ygcen.2014.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. Radioimmunoassay of leptin in human plasma. Clin. Chem. 1996;42(6):942–946. [PubMed] [Google Scholar]
  • 28.Maciver NJ, Jacobs SR, Wieman HL, Wofford JA, Coloff JL, Rathmell JC. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J. Leukoc. Biol. 2008;84:949–957. doi: 10.1189/jlb.0108024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J. Immunol. 2002;168(8):4018–4024. doi: 10.4049/jimmunol.168.8.4018. [DOI] [PubMed] [Google Scholar]
  • 30.Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno TA, Sang-Yong Kim S, Hamnvik OR, Koniaris A. Leptin in human physiology and pathophysiology. Am. J. Physiol. Endocrinol. Metab. 2011;301(4):E567–E584. doi: 10.1152/ajpendo.00315.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Maratou E, Dimitriadis G, Kollias A, Boutati E, Lambadiari V, Mitrou P, Raptis SA. Glucose transporter expression on the plasma membrane of resting cells and activated blood cells. Eur. J. Clin. Invest. 2007;37:282–290. doi: 10.1111/j.1365-2362.2007.01786.x. [DOI] [PubMed] [Google Scholar]
  • 32.Marti A, Marcos A, Martinez JA. Obesity and immune function relationship. Obes. Rev. 2001;2:131–140. doi: 10.1046/j.1467-789x.2001.00025.x. [DOI] [PubMed] [Google Scholar]
  • 33.Matarese G, Cava AL. The intricate interface between immune system and metabolism. Trends Immunol. 2004;25:193–200. doi: 10.1016/j.it.2004.02.009. [DOI] [PubMed] [Google Scholar]
  • 34.Matarese G, Moschos S, Mantzoros CS. Leptin in immunology. J. Immunol. 2005;174(6):3137–3142. doi: 10.4049/jimmunol.174.6.3137. [DOI] [PubMed] [Google Scholar]
  • 35.Moriguchi S, Kato M, Sakai K, Yamamoto S, Shimizu E. Decreased mitogen response of splenic lymphocytes in obese Zucker rats is associated with the decreased expression of glucose transporter 1 (GLUT-1) Am. J. Clin. Nutr. 1998;67:1124–1129. doi: 10.1093/ajcn/67.6.1124. [DOI] [PubMed] [Google Scholar]
  • 36.Moulin C, Moulin M, Marguti I, Peron JP, Rizzo LV, Halpern A. Impact of adiposity on immunological parameters. Arq Bras Endocrinol. Metab. 2009;53(2):183–189. doi: 10.1590/S0004-27302009000200010. [DOI] [PubMed] [Google Scholar]
  • 37.Muñoz M, Mazure RA, Culebras JM. Obesity and the immune system. Nutr. Hosp. 2004;19:319–324. [PubMed] [Google Scholar]
  • 38.Oleszczak B, Szablewski L, Pliszka M. The effect of hyperglycemia and hypoglycemia on glucose transport and expression of glucose transporters in human lymphocytes B and T: an in vitro study. Diabetes Res. Clin. Pract. 2012;96(2):170–178. doi: 10.1016/j.diabres.2011.12.012. [DOI] [PubMed] [Google Scholar]
  • 39.B. Oleszczak, L. Szablewski, M. Pliszka, O. Głuszak, U. Stopińska-Głuszak, Transport of deoxy-d-glucose into lymphocytes of patients with polycystic ovary syndrome. Endocrine. (2014) Feb 11. (Epub ahead of print) [DOI] [PMC free article] [PubMed]
  • 40.Papathanassoglou E, El-Haschimi K, Li XC, Matarese G, Strom T, Mantzoros C. Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. J. Immunol. 2006;176:7745–7752. doi: 10.4049/jimmunol.176.12.7745. [DOI] [PubMed] [Google Scholar]
  • 41.Pétervári E, Rostás I, Soós S, Tenk J, Mikó A, Füredi N, Székely M, Balaskó M. Age versus nutritional state in the development of central leptin resistance. Peptides. 2014;25(56C):59–67. doi: 10.1016/j.peptides.2014.03.011. [DOI] [PubMed] [Google Scholar]
  • 42.Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, Leibel RL. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J. Clin. Endocrinol. Metab. 1996;81(9):3424–3427. doi: 10.1210/jcem.81.9.8784109. [DOI] [PubMed] [Google Scholar]
  • 43.Saad MF, Damani S, Gingerich RL, Riad-Gabriel MG, Khan A, Boyadjian R, Jinagouda SD, El-Tawil K, Rude RK, Kamdar V. Sexual dimorphism in plasma leptin concentration. J. Clin. Endocrinol. Metab. 1997;82(2):579–584. doi: 10.1210/jcem.82.2.3739. [DOI] [PubMed] [Google Scholar]
  • 44.Sahu A. Intracellular leptin-signaling pathways in hypothalamic neurons: the emerging role of phosphatidylinositol-3 kinase-phosphodiesterase-3B-cAMP pathway. Neuroendocrinology. 2011;93(4):201–210. doi: 10.1159/000326785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Sánchez-Margalet V, Martín-Romero C, Santos-Alvarez J, Goberna R, Najib S, Gonzalez-Yanes C. Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin. Exp. Immunol. 2003;133:11–19. doi: 10.1046/j.1365-2249.2003.02190.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Saucillo DC, Gerriets VA, Sheng J, Rathmell JC, MacIver NJ. Leptin metabolically licenses T cells for activation to link nutrition and immunity. J. Immunol. 2014;192(1):136–144. doi: 10.4049/jimmunol.1301158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Sweeney G, Keen J, Somwar R, Konrad D, Garg R, Klip A. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in L6 rat skeletal muscle cells. Endocrinology. 2001;142:4806–4812. doi: 10.1210/endo.142.11.8496. [DOI] [PubMed] [Google Scholar]
  • 48.L. Szablewski, B. Oleszczak, J. Malejczyk, A. Osiecka, A. Hyc, P. Borsuk, Facilitative glucose transporters in rat chondrocytes. Eur. J. Cell Biol. suppl 113–115 (2000)
  • 49.Szablewski L, Sobczyk-Kopcioł A, Oleszczak B, Nowak Ł, Grytner-Zięcina B. GLUT 4 is expressed in circulating lymphocytes of diabetic patients. A method to detect early prediabetic stages? Diabetol. Croat. 2007;36:69–76. [Google Scholar]
  • 50.Wieman HL, Wofford JA, Rathmell JC. Cytokine stimulation promotes glucose uptake via PI3K/Akt regulation of Glut1 activity and trafficking. Mol. Biol. Cell. 2007;18:1437–1446. doi: 10.1091/mbc.E06-07-0593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.N. Yamamoto, M. Ueda, T. Sato, K. Kawasaki, K. Sawada, K. Kawabata, H. Ashida, Measurement of glucose uptake in cultured cells. Curr. Protoc. Pharmacol. 55:12.14.1–12.14.22 (2011) [DOI] [PubMed]
  • 52.Zarkesh-Esfahani H, Pockley G, Bidlingmaier M, Wu Z, Ajami A, Weetman AP, Strasburger CJ, Ross RJ. High-dose leptin activates human leukocytes via receptor expression on monocytes. J. Immunol. 2001;167:4593–4599. doi: 10.4049/jimmunol.167.8.4593. [DOI] [PubMed] [Google Scholar]
  • 53.Zhao Y, Sun R, You L, Gao C, Tian Z. Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem. Biophys. Res. Commun. 2003;300(2):47–252. doi: 10.1016/S0006-291X(02)02838-3. [DOI] [PubMed] [Google Scholar]
  • 54.Zysling DA, Demas GE. Metabolic stress suppresses humoral immune function in long-day, but not short-day, Siberian hamsters (Phodopus sungorus) J. Comp. Physiol. B. 2007;177:339–347. doi: 10.1007/s00360-006-0133-4. [DOI] [PubMed] [Google Scholar]

Articles from Endocrine are provided here courtesy of Springer

RESOURCES